Biofrontera Inc.: A Compelling Investment in Dermatology
October 28, 2025
Diffusion Pharmaceuticals Reports Positive Trend in Oxygenation from TCOM Trial
June 30, 2021
Related Post
-
-
Genprex Announces Registered Direct Offering of up to $8.1 Million Priced At-The-Market Under Nasdaq Rules
October 23, 2025
-
Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance
October 16, 2025
-
Dominari Securities Raises Over $1.4 Billion Year-to-Date in Support of American Innovation and Entrepreneurship
October 16, 2025